You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1956687 |
---|---|
Category | Proteins |
Description | B7-H4 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 52.3 kDa and the accession number is Q7Z7D3-1. |
Tag | C-hFc |
Purity | 98.00% |
MW | 52.3 kDa (predicted); 66-76 kDa (reducing conditions) |
UniProt ID | Q7Z7D3 |
Expression System | HEK293 Cells |
Biological Origin | Human |
Biological Activity | B7-H4 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 52.3 kDa and the accession number is Q7Z7D3-1. |
Expression Region | A DNA sequence encoding the human VTCN1 (Q7Z7D3-1) (Phe29-Ala258) was expressed, fused with the Fc region of human IgG1 at the C-terminus. Predicted N terminal: Phe 29 |
Storage | -20°C |
Note | For research use only |
Application notes | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
Expiration Date | 6 months from date of receipt. |
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining. | |
The protein has a predicted molecular mass of 51.4 kDa after removal of the signal peptide.The apparent molecular mass of B7-H4-hFc is approximately 100-130 kDa due to glycosylation. | |
Mammalian |
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining. | |
The protein has a predicted molecular mass of 38.7 kDa after removal of the signal peptide. The apparent molecular mass of B7-H4(147-259)-hFc is approximately 35-70 kDa due to glycosylation. | |
Mammalian |
The purity of the protein is greater than 95% as determined by SDS-PAGE and Coomassie blue staining. | |
The protein has a predicted molecular mass of 40.0 kDa after removal of the signal peptide. The apparent molecular mass of B7-H4(25-152)-hFc is approximately 35-55 kDa due to glycosylation. | |
Mammalian |
98.00% | |
52.3 kDa (predicted) |
98.00% | |
70-95 KDa (reducing condition) |